Value of combined midbrain sonography, olfactory and motor function assessment in the differential diagnosis of early Parkinson's disease

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 83, Issue 4, 2012, Pages 441-447

  Busse, Knut ^a   Heilmann, Robert ^b   Kleinschmidt, Sabine ^b   Abu Mugheisib, Mazen ^b   Höppner, Jacqueline ^b   Wunderlich, Christian ^a   Gemende, Irene ^a   Kaulitz, Lara ^b   Wolters, Alexander ^b   Benecke, Reiner ^b   Walter, Uwe ^b  

^a Parkinson Clinic Waldklinik Bernburg GmbH   (Germany)

^b UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN ASYMMETRY; CLINICAL FEATURE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE DURATION; EARLY DIAGNOSIS; ECHOENCEPHALOGRAPHY; ESSENTIAL TREMOR; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; HYPOSMIA; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL PERFORMANCE; MESENCEPHALON; MOTOR PERFORMANCE; OLFACTORY CORTEX; OLFACTORY DISCRIMINATION; PARKINSON DISEASE; PARKINSONISM; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; UNIFIED PARKINSON DISEASE RATING SCALE;

AGE OF ONSET; AGED; ALGORITHMS; COHORT STUDIES; COMORBIDITY; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MOVEMENT DISORDERS; OLFACTION DISORDERS; PARKINSON DISEASE; RETROSPECTIVE STUDIES; SUBSTANTIA NIGRA; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 84857999266     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2011-301719     Document Type: Article

References (40)

1. Hughes AJ, Daniel SE, Kilford L, et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-4.
2. Zijlmans JC, Daniel SE, Hughes AJ, et al. Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis. Mov Disord 2004;19:630-40. (Pubitemid 39173015)
3. Zijlmans J, Evans A, Fontes F, et al. [123I] FP-CIT SPECT study in vascular parkinsonism and Parkinson's disease. Mov Disord 2007;22:1278-85. (Pubitemid 47325035)
4. Gilman S, Wenning GK, Low PA, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008;71:670-6.
5. Lees AJ. When did Ray Kennedy's Parkinson's disease begin? Mov Disord 1992;7:110-16.
6. Lee CS, Schulzer M, Mak E, et al. Patterns of asymmetry do not change over the course of idiopathic parkinsonism: implications for pathogenesis. Neurology 1995;45:435-9.
7. Berg D, Godau J, Walter U. Transcranial sonography in movement disorders. Lancet Neurol 2008;7:1044-55.
8. Haehner A, Boesveldt S, Berendse HW, et al. Prevalence of smell loss in Parkinson's disease - a multicenter study. Parkinsonism Relat Disord 2009;15:490-4.
9. Yamanouchi H, Nagura H. Neurological signs and frontal white matter lesions in vascular parkinsonism. A clinicopathologic study. Stroke 1997;28:965-9. (Pubitemid 27209142)
10. Pause BM, Miranda A, Göder R, et al. Reduced olfactory performance in patients with major depression. J Psychiatr Res 2001;35:271-7. (Pubitemid 32928428)
11. McKinnon JH, Demaerschalk BM, Caviness JN, et al. Sniffing out Parkinson disease: can olfactory testing differentiate parkinsonian disorders? Neurologist 2007;13:382-5. (Pubitemid 350307683)
12. Walter U, Hoeppner J, Prudente-Morrissey L, et al. Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders. Brain 2007;130:1799-807. (Pubitemid 47343787)
13. Fahn S, Elton RL; Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Goldstein M, et al, eds. Recent developments in Parkinson's DISEASE II. New York, NY: Macmillan, 1987:153-63.
14. Goetz CG, Poewe W, Rascol O, et al Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord 2004;19:1020-8. (Pubitemid 39302834)
15. Litvan I. Update on progressive supranuclear palsy. Curr Neurol Neurosci Rep 2004;4:296-302. (Pubitemid 39023099)
16. Bain P, Brin M, Deuschl G, et al. Criteria for the diagnosis of essential tremor. Neurology 2000;54(Suppl 4):S7. (Pubitemid 30390608)
17. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th edn. Washington DC: American Psychiatric Association, 1994.
18. Hassin-Baer S, Sirota P, Korczyn AD, et al. Clinical characteristics of neuroleptic-induced parkinsonism. J Neural Transm 2001;108:1299-308. (Pubitemid 33141304)
19. Hummel T, Konnerth CG, Rosenheim K, et al. Screening of olfactory function with a four-minute odor identification test: reliability, normative data, and investigations in patients with olfactory loss. Ann Otol Rhinol Laryngol 2001;110:976-81. (Pubitemid 32979994)
20. van de Loo S, Walter U, Behnke S, et al. Reproducibility and diagnostic accuracy of substantia nigra sonography for the diagnosis of Parkinson's disease. J Neurol Neurosurg Psychiatry 2010;81:1087-92.
21. Uitti RJ, Baba Y, Whaley NR, et al. Parkinson disease: handedness predicts asymmetry. Neurology 2005;64:1925-30. (Pubitemid 40800708)
22. Rodriguez M, Lera G, Vaamonde J, et al. Motor response to apomorphine and levodopa in asymmetric Parkinson's disease. J Neurol Neurosurg Psychiatry 1994;57:562-6. (Pubitemid 24151247)
23. Silveira-Moriyama L, Sirisena D, Gamage P, et al. Adapting the sniffin' sticks to diagnose Parkinson's disease in Sri Lanka. Mov Disord 2009;24:1229-33.
24. Litvan I, MacIntyre A, Goetz CG, et al. Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study. Arch Neurol 1998;55:969-78. (Pubitemid 28335116)
25. Stern MB, Doty RL, Dotti M, et al. Olfactory function in Parkinson's disease subtypes. Neurology 1994;44:266-8. (Pubitemid 24070964)
26. Herting B, Schulze S, Reichmann H, et al. A longitudinal study of olfactory function in patients with idiopathic Parkinson's disease. J Neurol 2008;255:367-70.
27. Ponsen MM, Stoffers D, Booij J, et al. Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Ann Neurol 2004;56:173-81. (Pubitemid 39037913)
28. Haehner A, Hummel T, Hummel C, et al. Olfactory loss may be a first sign of idiopathic Parkinson's disease. Mov Disord 2007;22:839-42.
29. Berg D, Seppi K, Liepelt I, et al. Enlarged hyperechogenic substantia nigra is related to motor performance and olfaction in the elderly. Mov Disord 2010;25:1464-9.
30. Walter U, Klein C, Hilker R, et al. Brain parenchyma sonography detects preclinical parkinsonism. Mov Disord 2004;19:1445-9. (Pubitemid 40104051)
31. Berg D, Merz B, Reiners K, et al. Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease. Mov Disord 2005;20:383-5. (Pubitemid 40613305)
32. Unger MM, Möller JC, Stiasny-Kolster K, et al. Assessment of idiopathic rapid-eye-movement sleep behavior disorder by transcranial sonography, olfactory function test, and FP-CIT-SPECT. Mov Disord 2008;23:596-9.
33. Gaenslen A, Unmuth B, Godau J, et al. The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease: a prospective blinded study. Lancet Neurol 2008;7:417-24.
34. Berg D, Seppi K, Behnke S, et al. Enlarged substantia nigra hyperechogenicity and risk for Parkinson disease: a 37-month 3-center study of 1847 older persons. Arch Neurol 2011;68:932-7.
35. Walter U, Dressler D, Probst T, et al. Transcranial brain sonography findings in discriminating between parkinsonism and idiopathic Parkinson disease. Arch Neurol 2007;64:1635-40. (Pubitemid 350106766)
36. Iwanami M, Miyamoto T, Miyamoto M, et al. Relevance of substantia nigra hyperechogenicity and reduced odor identification in idiopathic REM sleep behavior disorder. Sleep Med 2010;11:361-5.
37. Ruprecht-Dörfler P, Klotz P, Becker G, et al. Substantia nigra hyperechogenicity correlates with subtle motor dysfunction in tap dancers. Parkinsonism Relat Disord 2007;13:362-4. (Pubitemid 47212783)
38. Hoeppner J, Prudente-Morrissey L, Herpertz SC, et al. Substantia nigra hyperechogenicity in depressive subjects relates to motor asymmetry and impaired word fluency. Eur Arch Psychiatry Clin Neurosci 2009;259:92-7.
39. Lang AE. A critical appraisal of the premotor symptoms of Parkinson's disease: potential usefulness in early diagnosis and design of neuroprotective trials. Mov Disord 2011;26:775-83.
40. Go CL, Frenzel A, Rosales RL, et al. Assessment of substantia nigra echogenicity in German and Filipino population using a portable ultrasound system. J Ultrasound Med 2012;31:191-6.